Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment

• Tao Jiang,
• Qingzhu Jia,
• Wenfeng Fang,
• Shengxiang Ren,
• Xiaoxia Chen,
• Chunxia Su,
• Li Zhang,
• Caicun Zhou

Affiliations

Tao Jiang

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute Tongji University School of Medicine Shanghai China

Qingzhu Jia

Institute of Cancer, Xinqiao Hospital Third Military Medical University Chongqing China

Wenfeng Fang

State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Department of Medical Oncology Sun Yat‐sen University Cancer Center Guangzhou China

Shengxiang Ren

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute Tongji University School of Medicine Shanghai China

Xiaoxia Chen

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute Tongji University School of Medicine Shanghai China

Chunxia Su

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute Tongji University School of Medicine Shanghai China

Li Zhang

State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Department of Medical Oncology Sun Yat‐sen University Cancer Center Guangzhou China

Caicun Zhou

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute Tongji University School of Medicine Shanghai China